Citius Pharmaceuticals In...
(CTXR) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
3.89
5.14%
After-hours Jan 08, 2025, 06:27 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
PE Ratio | n/a | -76.83 | -131.36 | -238.33 | -57.62 | -24.51 | -35.74 | -41.61 | -103.13 | -466.19 | n/a | -8.96K | -12.77K | -10.67K |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | n/a | 27.53 | 42.98 | 41.70 | 30.24 | 15.66 | 16.08 | 19.69 | 51.03 | -2.13K | n/a | -19.13K | -6.13K | -11.79K |
P/FCF Ratio | n/a | -86.04 | -155.81 | -85.77 | -60.14 | -30.7 | -39.59 | -54.2 | -145 | -567.2 | n/a | -13.64K | -13.83K | -13.53K |
P/OCF Ratio | n/a | -86.04 | -155.81 | -227.27 | -60.15 | -30.7 | -39.59 | -54.21 | -145 | -567.2 | n/a | -13.64K | -13.83K | -13.53K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | n/a | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | n/a | -0.81 | -0.22 | n/a | n/a |
Quick Ratio | 0.17 | 5.95 | 9.84 | 18.28 | 3.41 | 1.72 | 3.16 | 1.39 | 0.17 | 0.53 | 0.67 | 6.98 | 0.00 | 0.01 |
Current Ratio | 0.40 | 5.95 | 9.84 | 18.28 | 3.41 | 1.72 | 3.16 | 1.39 | 0.17 | 0.53 | 0.67 | 6.98 | 0.00 | 0.01 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | -132.52 | -2.17K | -1.13K | -948.63 | -870.64 | -11.74 | -828.25 | -430.66 | n/a | -8.65 | -8.22 | n/a |
Return on Equity (ROE) | -0.56 | -0.36 | -0.33 | -0.17 | -0.52 | -0.64 | -0.45 | -0.47 | -0.49 | 4.57 | 1.71 | 2.13 | 0.48 | 1.10 |
Return on Assets (ROA) | -0.34 | -0.31 | -0.3 | -0.16 | -0.4 | -0.54 | -0.4 | -0.43 | -0.38 | -3.91 | -0.82 | -0.29 | -163.01 | -124.25 |
Return on Capital (ROIC) | n/a | -0.38 | -0.3 | -0.17 | -0.45 | -0.64 | -0.49 | -0.46 | -0.44 | 5.08 | 1.55 | -0.3 | 0.43 | 1.08 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |